Savio John
Appearances
- DateMay 21, 2024Rifaximin and lactulose are widely used in patients with hepatic encephalopathy. Limited data exists on the comparative outcomes regarding spontaneous bacterial peritonitis (SBP), renal adverse events and ER visits in patients with cirrhosis on rifaximin versus lactulose-based therapy…
- DateMay 21, 2024There are controversial studies regarding the use of nonselective beta blockers (NSBB) in patients with cirrhosis and history of spontaneous bacterial peritonitis (SBP). We designed a study to investigate the effect of NSBB on mortality in patients with cirrhotic ascites and history of SBP…